Relistor

Coyne PR provides public relations strategy and communications support to Salix Pharmaceuticals and its brand Relistor – a treatment indicated for opioid-induced constipation (OIC). Through the years, we have helped conceptualize and execute initiatives to drive visibility of Relistor, both internally and externally, and increase engagement with key stakeholders nationally, locally and online. From media relations to disease awareness programs to sponsorship activations, Coyne has helped elevate the Relistor reputation while educating about OIC.